Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sumitomo chemical australia pty. limited - esfenvalerate; esfenvalerate; liquid hydrocarbon; liquid hydrocarbon - emulsifiable concentrate - esfenvalerate pyrethroid active 50.0 g/l; esfenvalerate pyrethroid active 50.0 g/l; liquid hydrocarbon solvent other 744.0 g/l; liquid hydrocarbon solvent other 768.0 g/l - insecticide - barley | brassica spp. or cole crop | broad bean | broccoli | brussels sprouts | bush tomato | cabbage | canola | cauliflower | - anthelid caterpillar | aphids - rhopalosiphum spp. | barley yellow dwarf virus | blue oat or pea mite | bluegreen aphid | brown pasture looper | cabbage center grub | cabbage moth | cabbage white butterfly | cluster caterpillar | common armyworm | corn earworm | cowpea aphid | cutworm - agrotis spp. | garden or south african vine weevil | helicoverpa armigera | helicoverpa larvae | helicoverpa punctigera | jassids | lucerne leafroller | lucerne seed web moth | native budworm or bollworm | native budworm or bollworm - larvae | pasture webworm - hednota spp. | pea weevil | pinkspotted bollworm | plague thrips | redlegged earth mite | sorghum midge | southern or barley armyworm | soybean looper | tobacco looper or looper caterpillar | tomato grub | vegetable weevil | wingless grasshopper | barley armyworm | barley grub | barley yellow dwarf virus vect | bollworm | corn earworm | cotton bollworm | desiantha weevil (wa) | diachrysia orichalceaa | diamondback moth | garden weevil | helicoverpa armigera | helicoverp

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - alpha-cypermethrin; liquid hydrocarbon - emulsifiable concentrate - alpha-cypermethrin pyrethroid active 100.0 g/l; liquid hydrocarbon solvent other 760.0 g/l - insecticide - apple | apricot | asparagus - except white asparagus | banksia | broccoli | brussels sprouts | cabbage | canola | cauliflower | - aphids - rhopalosiphum spp. | apple dimpling bug - c. liebknechti | apple weevil | autumn gum moth | banksia moth - danima banksiae | blackheaded pasture cockchafer | blue oat or pea mite | bronzed field beetle | brown pasture looper | cabbage moth | cabbage white butterfly | cadmus spp. | cluster caterpillar | common armyworm - mythimna convecta | corn earworm | cotton budworm or bollworm | cutworm - agrotis spp. | eucalyptus weevil | garden or south african vine weevil | green mirid bug | grey cluster bug | helicoverpa armigera | helicoverpa spp. | liparetrus spp. - adults | native budworm or bollworm | pasture webworm - hednota spp. | pea weevil | pink or brown cutworm | plague thrips | redlegged earth mite | rice bloodworm | rough bollworm | rutherglen bug | sorghum midge | southern or barley armyworm | tasmanian eucalyptus leaf beetle | tobacco budworm | tobacco looper or looper caterpillar | tomato grub | vegetable weevil | wingless grasshopper | acrossidius tasmaniae | barley armyworm | barley grub | b

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - deltamethrin; liquid hydrocarbon - emulsifiable concentrate - deltamethrin pyrethroid active 27.5 g/l; liquid hydrocarbon solvent other 811.0 g/l - insecticide - berry vegetable | broccoli | brussels sprouts | cabbage | canola oilseed crop | cape gooseberry | cauliflower | cereals | chickp - cabbage center grub | cabbage moth | cabbage white butterfly | common armyworm - mythimna convecta | corn earworm | cotton budworm or bollworm | cutworm - agrotis spp. | green mirid bug | green vegetable bug | helicoverpa spp. | jassids | looper | native budworm or bollworm | pea weevil | pink spotted bollworm moth | rutherglen bug | sorghum midge | southern or barley armyworm | thrip | tobacco budworm | tobacco looper or looper caterpillar | tobacco stem borer | tomato grub | webworm - hednota pedionoma | barley armyworm | barley grub | corn earworm | cotton bollworm | diamondback moth | heliothis | leucania convecta | looper caterpillars | native bollworm | native budworm | pasture webworm | southern armyworm | stem borer | thrips spp. | tobacco budworm | tomato grub

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sinon australia pty limited - alpha-cypermethrin; liquid hydrocarbon - emulsifiable concentrate - alpha-cypermethrin pyrethroid active 100.0 g/l; liquid hydrocarbon solvent other 729.0 g/l - insecticide

Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - alpha-cypermethrin; liquid hydrocarbons present as liquid paraffin - emulsifiable concentrate - alpha-cypermethrin pyrethroid active 100.0 g/l; liquid hydrocarbons present as liquid paraffin ungrouped other 755.0 g/l - insecticide

Verenigde Staten - Engels - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - omeprazole magnesium (unii: 426qfe7xlk) (omeprazole - unii:kg60484qx9) - omeprazole 10 mg - prilosec is indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. triple therapy prilosec in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. dual therapy prilosec in combination with clarithromycin is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. among patients who fail therapy, prilosec with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in patients who fail therapy, susceptibility testing should be done. if resistance to clarithromycin is demonstrated or susceptibility testing is not pos

Verenigde Staten - Engels - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - rabeprazole sodium (unii: 3l36p16u4r) (rabeprazole - unii:32828355ll) - rabeprazole sodium 20 mg - rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (gerd). for those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium may be considered. rabeprazole sodium delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (gerd maintenance). controlled studies do not extend beyond 12 months. rabeprazole sodium delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks. rabeprazole sodium delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers. most patients heal within four weeks. rabeprazole sodium delayed-release t

Verenigde Staten - Engels - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 20 mg - omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence.   triple therapy omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults.   dual therapy omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults.   among patients who fail therapy, omeprazole delayed-release capsules are with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. in patients who fail therapy, su

Verenigde Staten - Engels - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - rabeprazole sodium (unii: 3l36p16u4r) (rabeprazole - unii:32828355ll) - rabeprazole sodium 20 mg - rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (gerd). for those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium delayed-release tablets may be considered. rabeprazole sodium delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (gerd maintenance). controlled studies do not extend beyond 12 months. rabeprazole sodium delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks. rabeprazole sodium delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers. most patients heal within four weeks. rabeprazole

Verenigde Staten - Engels - NLM (National Library of Medicine)

golden state medical supply, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - omeprazole 20 mg - omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. most patients heal within four weeks. some patients may require an additional four weeks of therapy. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence. omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate h. pylori in adults. omeprazole delayed-release capsules in combination with clarithromycin is indicated for treatment of patients with h. pylori infection and duodenal ulcer disease to eradicate h. pylori in adults. among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin are more likely to be associated with the development of clarithromycin resistance as compared with trip